BC-Plex WGA of Bisulfite-Converted DNA

Amplification of Bisulfite-Converted Short Double-Stranded DNA

BC-Plex WGA enables small amounts of DNA from clinical samples to be bisulfite converted and amplified, giving you:

• Unlimited quantities of bisulfite-converted DNA for analysis
• Microarray and NGS profiling of DNA methylation from plasma, serum, urine and other fragmented clinical samples
• Non-invasive IVD-MIA tests of plasma/serum for cancer and other diseases
• The ability to apply pyrosequencing and NGS to determine methylation of chromatin immunoprecipitation (ChIP) samples from small numbers of cells
• Increased sensitivity for non-invasive diagnostic, prognostic, and predictive cancer tests

In less than five hours, create enough bisulfite-converted DNA to perform sensitive Q-PCR, microarray, and NGS studies starting from <10 nanograms of sample DNA.
BC-Plex WGA delivers faster, simpler, reproducible analysis of many clinical and research samples.

BC-Plex is in development.